South Korea · Delayed Price · Currency is KRW Genic Statistics
Total Valuation
Genic has a market cap or net worth of KRW 180.36 billion. The enterprise value is 177.68 billion.
| Market Cap | 180.36B |
| Enterprise Value | 177.68B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genic has 7.82 million shares outstanding. The number of shares has increased by 3.64% in one year.
| Current Share Class | 7.82M |
| Shares Outstanding | 7.82M |
| Shares Change (YoY) | +3.64% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 5.37% |
| Float | 4.72M |
Valuation Ratios
The trailing PE ratio is 9.57.
| PE Ratio | 9.57 |
| Forward PE | n/a |
| PS Ratio | 2.01 |
| PB Ratio | 4.05 |
| P/TBV Ratio | 4.05 |
| P/FCF Ratio | 31.58 |
| P/OCF Ratio | 17.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.56, with an EV/FCF ratio of 31.11.
| EV / Earnings | 9.43 |
| EV / Sales | 1.98 |
| EV / EBITDA | 10.56 |
| EV / EBIT | 12.15 |
| EV / FCF | 31.11 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.95 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.48 |
| Interest Coverage | 44.44 |
Financial Efficiency
Return on equity (ROE) is 53.67% and return on invested capital (ROIC) is 40.41%.
| Return on Equity (ROE) | 53.67% |
| Return on Assets (ROA) | 16.86% |
| Return on Invested Capital (ROIC) | 40.41% |
| Return on Capital Employed (ROCE) | 31.12% |
| Weighted Average Cost of Capital (WACC) | 7.60% |
| Revenue Per Employee | 276.93M |
| Profits Per Employee | 58.17M |
| Employee Count | 324 |
| Asset Turnover | 1.66 |
| Inventory Turnover | 7.14 |
Taxes
| Income Tax | -4.22B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.28% in the last 52 weeks. The beta is 0.60, so Genic's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -36.28% |
| 50-Day Moving Average | 26,556.60 |
| 200-Day Moving Average | 23,426.95 |
| Relative Strength Index (RSI) | 47.58 |
| Average Volume (20 Days) | 219,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genic had revenue of KRW 89.73 billion and earned 18.85 billion in profits. Earnings per share was 2,408.73.
| Revenue | 89.73B |
| Gross Profit | 22.82B |
| Operating Income | 14.63B |
| Pretax Income | 14.63B |
| Net Income | 18.85B |
| EBITDA | 16.83B |
| EBIT | 14.63B |
| Earnings Per Share (EPS) | 2,408.73 |
Balance Sheet
The company has 5.39 billion in cash and 2.72 billion in debt, with a net cash position of 2.67 billion or 341.82 per share.
| Cash & Cash Equivalents | 5.39B |
| Total Debt | 2.72B |
| Net Cash | 2.67B |
| Net Cash Per Share | 341.82 |
| Equity (Book Value) | 44.56B |
| Book Value Per Share | 5,691.14 |
| Working Capital | 18.94B |
Cash Flow
In the last 12 months, operating cash flow was 10.54 billion and capital expenditures -4.82 billion, giving a free cash flow of 5.71 billion.
| Operating Cash Flow | 10.54B |
| Capital Expenditures | -4.82B |
| Depreciation & Amortization | 2.20B |
| Net Borrowing | -5.34B |
| Free Cash Flow | 5.71B |
| FCF Per Share | 729.92 |
Margins
Gross margin is 25.44%, with operating and profit margins of 16.30% and 21.00%.
| Gross Margin | 25.44% |
| Operating Margin | 16.30% |
| Pretax Margin | 16.31% |
| Profit Margin | 21.00% |
| EBITDA Margin | 18.75% |
| EBIT Margin | 16.30% |
| FCF Margin | 6.37% |
Dividends & Yields
Genic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.64% |
| Shareholder Yield | -3.64% |
| Earnings Yield | 10.45% |
| FCF Yield | 3.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0103113 |
Scores
Genic has an Altman Z-Score of 8.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.2 |
| Piotroski F-Score | 4 |